HP
Herminia Pierceover 2 years ago
What is the AZD-1222 coronavirus disease 2019 (COVID-19) vaccine?
Top rated comment
over 2 years ago
AZD-1222 (ChAdOx1 nCoV-19; AstraZeneca) COVID-19 vaccine is derived from viral vector method of technology. AZD-1222 (ChAdOx1 nCoV-19; AstraZeneca) COVID-19 vaccine contains surface glycoprotein antigen gene. Dose series = 1 dose given as half, both half doses have difference of 8-12 weeks Vaccine efficacy = 63.09% Safety concerns = none
Other commentsSign in to post comments. You don't have an account? Sign up now!
Related posts
South Africa Halts AstraZeneca Vaccine RolloutWhat is the mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine?What is the Moderna (mRNA-1273) COVID-19 vaccine?What is the Ad26.COV2.S coronavirus disease 2019 (COVID-19) vaccine?What is the Pfizer-Biotech (BNT162b2) COVID-19 vaccine?What is the NVX-CoV2373 coronavirus disease 2019 (COVID-19) vaccine?Are vaccines harmful?Types of VaccinePancreatic Endocrine Cells typesFunction of hypothalamus